XNAS
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-11 | Q3 2026 | -0.21 | -0.36 | -71.43% | $0 | ❌ Miss | +0.62% | -4.04% | +9.93% |
| 2025-11-12 | Q2 2026 | -0.46 | -1.38 | -200.00% | $0 | ❌ Miss | — | — | — |
| 2025-08-13 |
| Q1 2026 |
| — |
| -1.07 |
| — |
| $0 |
| — |
| -0.90% |
| -5.41% |
| +0.00% |
| 2025-02-13 | Q3 2025 | -2.40 | -1.46 | +39.17% | $0 | ✅ Beat | -0.35% | +2.81% | -30.16% |
| 2024-11-11 | Q2 2025 | — | -2.47 | — | $0 | — | -0.47% | +16.34% | -68.54% |
| 2024-08-13 | Q1 2025 | — | -2.80 | — | $0 | — | -5.14% | -1.88% | +33.64% |
| 2024-05-31 | Q4 2024 | — | -6.20 | — | $0 | — | -10.53% | -39.91% | -58.33% |
| 2024-02-13 | Q3 2024 | — | -4.60 | — | $0 | — | — | — | — |
Showing last 8 quarters.